A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Global Anti-snoring Devices Market 2023: Increased Awareness of the Negative Consequences of Snoring Drives Growth

The “Global Anti-Snoring Devices Market Overview, 2023-28” report has been added to ResearchAndMarkets.com’s offering.

According to this report the global anti-snoring device market is expected to reach more than USD 2 Billion by 2028, with a CAGR of 7.92% from USD 1.47 Billion in 2022.

Company Profile

  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Fisher & Payker Healthcare
  • SomnoMed Inc
  • Medtronic plc
  • Meditas Ltd.
  • Resmed
  • Airway Management Inc.
  • SnoreMeds
  • puresleep

An increase in tobacco and alcohol consumption, as well as increased awareness of the negative consequences of snoring caused by these factors, are driving the market. Throughout the forecast period, technological advancements in the market will drive the global anti-snoring device market.

Furthermore, low-cost and minimally invasive devices, combined with associated product benefits, may drive demand. Additionally, the rising prevalence of obesity, diabetes, and other chronic diseases has an effect. Furthermore, an increase in the geriatric population base susceptible to obesity boosts demand for anti-snoring products.

The growing patient preference for anti-snoring devices will drive demand for such devices, propelling the anti-snoring device market forward. Furthermore, rising snoring awareness, increased disposable income, and advanced product development will drive demand for anti-snoring devices in the coming years.

Snoring and sleep apnea are common sleep disorders that affect millions of people worldwide. As the global population continues to grow and age, the prevalence of these disorders is expected to increase, driving demand for anti-snoring devices. Furthermore, obesity is a major risk factor for snoring and sleep apnea, and with the global rise in obesity rates, the prevalence of these sleep disorders is expected to increase, driving demand for anti-snoring devices.

Moreover, the emergence of smart anti-snoring devices, the market entry of sleep-based start-up companies, the emergence of the latest generation of Herbst-style oral appliances, and new launches and approvals of anti-snoring devices are some significant trends in the anti-snoring devices market.

The global anti-snoring device market is subject to various regulatory requirements, such as safety and efficacy standards. Compliance with these regulations can be challenging and costly, which can limit the entry of new players and limit the overall market growth. Furthermore, some anti-snoring devices may cause discomfort or side effects, such as dry mouth, sore throat, or nasal congestion. This can lead to low compliance and limit the overall market growth. Moreover, here are alternative treatments for snoring and sleep apnea, such as surgery or positional therapy. Some people may choose these alternatives instead of using anti-snoring devices, which can limit the overall market growth.


  • In May 2022, Illusion Aligners launched a new innovative anti-snoring device. This Illusion Aligner oral anti-snoring device is easy to wear, effective, and comfortable. It helps the user to experience an undisturbed and peaceful sleep every night.
  • In February 2021, Signifier Medical Technologies launched an innovative anti-snoring device, eXciteOSA, and the device works by producing electrical muscle stimulation through a mouthpiece around the tongue. The device has four electrodes, two located above the tongue and two below the tongue. The U.S. FDA approved the commercialization of a prescription-only anti-snoring device, ”eXciteOSA”.

Considered in this report

  • Geography: Global
  • Historic year: 2017
  • Base year: 2022
  • Estimated year: 2023
  • Forecast year: 2028

Key Topics Covered:

1. Executive Summary

2. Market Dynamics

2.1. Market Drivers

2.2. Challenges

2.3. Opportunity

2.4. Restraints

2.5. Market Trends

2.6. Covid-19 Effect

2.7. Supply chain Analysis

2.8. Policy & Regulatory Framework

2.9. Industry Experts Views

3. Research Methodology

3.1. Secondary Research

3.2. Primary Data Collection

3.3. Market Formation & Validation

3.4. Report Writing, Quality Check & Delivery

4. Market Structure

4.1. Market Considerate

4.2. Assumptions

4.3. Limitations

4.4. Abbreviations

4.5. Sources

4.6. Definitions

5. Economic /Demographic Snapshot

6. Competitive Landscape

6.1. Competitive Dashboard

6.2. Business Strategies Adopted by Key Players

6.3. Key Players Market Share Insights and Analysis, 2022

6.4. Key Players Market Positioning Matrix

6.5. Consolidated SWOT Analysis of Key Players

6.6. Porter’s Five Forces

7. Global Anti-Snoring Market Outlook

7.1. Market Size By Value

7.2. Market Size and Forecast, By Geography

7.3. Market Size and Forecast, By Product Type

7.4. Market Size and Forecast, By Distribution Channel

8. North America Anti-Snoring Market Outlook

8.1. Market Size By Value

8.2. Market Share By Country

8.3. Market Size and Forecast By Product Type

8.4. Market Size and Forecast By Distribution Channel

9. Europe Anti-Snoring Market Outlook

9.1. Market Size By Value

9.2. Market Share By Country

9.3. Market Size and Forecast By Product Type

9.4. Market Size and Forecast By Distribution Channel

10. Asia-Pacific Anti-Snoring Market Outlook

10.1. Market Size By Value

10.2. Market Share By Country

10.3. Market Size and Forecast By Product Type

10.4. Market Size and Forecast By Distribution Channel

11. South America Anti-Snoring Market Outlook

11.1. Market Size By Value

11.2. Market Share By Country

11.3. Market Size and Forecast By Product Type

11.4. Market Size and Forecast By Distribution Channel

12. Middle East & Africa Anti-Snoring Market Outlook

12.1. Market Size By Value

12.2. Market Share By Country

12.3. Market Size and Forecast By Product Type

12.4. Market Size and Forecast By Distribution Channel

13. Company Profile

14. Strategic Recommendations

15. Annexure

16. Disclaimer

For more information about this report visit https://www.researchandmarkets.com/r/uls2ty

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy